RenovoRx, Inc. (RNXT) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Mountain View, CA, 美国. 现任CEO为 Shaun R. Bagai.
RNXT 拥有 IPO日期为 2021-08-26, 10 名全职员工, 在 NASDAQ Capital Marke, 市值为 $36.15M.
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.
